Home › Rankings › Operating margin

Operating margin ranking (listed companies with ₩100B+ revenue)

Listed Korean companies ranked by operating profit as a share of revenue in their latest fiscal year, among companies with at least ₩100 billion of revenue.

At a glance

1,376 companies have a value for this ranking. Woori Technology Investment is first at 84.8%, followed by SHIFT UP Corporation. (61.6%) and Hpsp (52%).

The 10th company, HANMI Semiconductor, is at 43.6%, and the 100th, Samyang Comtech, at 17.2%.

Of the 100 companies listed below, 37 are on KOSPI and 63 on KOSDAQ.

Top 100

Rank · CompanyOperating margin
1 Woori Technology Investment KOSDAQ · 2025 revenue ₩163B84.8%
2 SHIFT UP Corporation. KOSPI · 2025 revenue ₩295B61.6%
3 Hpsp KOSDAQ · 2025 revenue ₩173B52%
4 Classys KOSDAQ · 2025 revenue ₩337B50.7%
5 Alteogen KOSDAQ · 2025 revenue ₩216B49.5%
6 SK hynix KOSPI · 2025 revenue ₩97.15T48.6%
7 LEENO Industrial KOSDAQ · 2025 revenue ₩373B47.5%
8 Hugel KOSDAQ · 2025 revenue ₩425B47.2%
9 Samsung Biologics KOSPI · 2025 revenue ₩4.56T45.4%
10 HANMI Semiconductor KOSPI · 2025 revenue ₩577B43.6%
11 EuBiologics KOSDAQ · 2025 revenue ₩149B40.7%
12 PharmaResearch KOSDAQ · 2025 revenue ₩536B40%
13 Sanil Electric KOSPI · 2025 revenue ₩502B35.6%
14 PSK Holdings KOSDAQ · 2025 revenue ₩208B35.3%
15 WON Tech KOSDAQ · 2025 revenue ₩157B33%
16 Cmtx KOSDAQ · 2025 revenue ₩161B32.3%
17 DoubleUGames KOSPI · 2025 revenue ₩720B32.2%
18 Myungin Pharm KOSPI · 2025 revenue ₩287B32.2%
19 Krafton KOSPI · 2025 revenue ₩3.33T31.7%
20 i-Scream Media KOSDAQ · 2025 revenue ₩196B31.5%
21 Korea Ratings KOSDAQ · 2025 revenue ₩110B31.3%
22 Pharmicell KOSPI · 2025 revenue ₩114B30.1%
23 Cheryong Electric KOSDAQ · 2025 revenue ₩224B29.9%
24 SK biopharmaceuticals KOSPI · 2025 revenue ₩707B28.9%
25 Kona I KOSDAQ · 2025 revenue ₩309B28.8%
26 Vitzrocell KOSDAQ · 2025 revenue ₩243B28.5%
27 GwangjuShinsegae. KOSPI · 2025 revenue ₩184B28.5%
28 Seobu T&D KOSDAQ · 2025 revenue ₩248B28.3%
29 Hankook & Company KOSPI · 2025 revenue ₩1.46T28.2%
30 T&L KOSDAQ · 2025 revenue ₩164B28.2%
31 Celltrion KOSPI · 2025 revenue ₩4.16T28.1%
32 Tokai Carbon Korea KOSDAQ · 2025 revenue ₩301B27.8%
33 Hy-Lok KOSDAQ · 2025 revenue ₩215B27.5%
34 ISC KOSDAQ · 2025 revenue ₩220B27.3%
35 Soop KOSDAQ · 2025 revenue ₩467B26.8%
36 Humedix KOSDAQ · 2025 revenue ₩170B24.9%
37 HD Hyundai Electric KOSPI · 2025 revenue ₩4.08T24.4%
38 F&F KOSPI · 2025 revenue ₩1.93T24.2%
39 Daehan Shipbuilding KOSPI · 2025 revenue ₩1.23T23.9%
40 APR KOSPI · 2025 revenue ₩1.53T23.9%
41 Suprema KOSDAQ · 2025 revenue ₩137B23.8%
42 F&F Holdings KOSPI · 2025 revenue ₩1.93T22.5%
43 Samyang Foods KOSPI · 2025 revenue ₩2.35T22.3%
44 Y-Entec KOSDAQ · 2025 revenue ₩117B22.3%
45 Hantech KOSDAQ · 2025 revenue ₩172B22.2%
46 eSANGNetworks KOSDAQ · 2025 revenue ₩104B22.1%
47 Lotte Tour Development KOSPI · 2025 revenue ₩653B21.9%
48 Neopharm KOSDAQ · 2025 revenue ₩132B21.8%
49 SUN Kwang KOSDAQ · 2025 revenue ₩190B21.7%
50 Seoho Electric KOSDAQ · 2025 revenue ₩117B21.7%
51 Sunic System KOSDAQ · 2025 revenue ₩516B21.6%
52 DIT KOSDAQ · 2025 revenue ₩108B21.4%
53 EO Technics KOSDAQ · 2025 revenue ₩381B21.2%
54 KakaoBank KOSPI · 2025 revenue ₩3.09T21%
55 Metabiomed KOSDAQ · 2025 revenue ₩103B20.8%
56 S&S Tech KOSDAQ · 2025 revenue ₩244B20.7%
57 Park Systems KOSDAQ · 2025 revenue ₩206B20.5%
58 Kt&g KOSPI · 2025 revenue ₩6.58T20.4%
59 Solborn KOSDAQ · 2025 revenue ₩121B20.4%
60 Protec KOSDAQ · 2025 revenue ₩231B20.1%
61 Worldexindustry&trading KOSDAQ · 2025 revenue ₩292B20.1%
62 DB HiTek KOSPI · 2025 revenue ₩1.40T19.8%
63 Ubiquoss KOSDAQ · 2025 revenue ₩116B19.8%
64 Ubiquoss Holdings KOSDAQ · 2025 revenue ₩156B19.7%
65 KSS Line KOSPI · 2025 revenue ₩561B19.7%
66 Korea Information Certificate Authority, Incorporated KOSDAQ · 2025 revenue ₩138B19.5%
67 d'Alba Global KOSPI · 2025 revenue ₩520B19.5%
68 Dongaeltek KOSDAQ · 2025 revenue ₩582B19.4%
69 PSK KOSDAQ · 2025 revenue ₩457B19.4%
70 JVM KOSDAQ · 2025 revenue ₩173B19.2%
71 VT KOSDAQ · 2025 revenue ₩437B19%
72 JYP Entertainment KOSDAQ · 2025 revenue ₩822B18.9%
73 HD-Hyundai Marine Engine KOSPI · 2025 revenue ₩402B18.9%
74 Isupetasys KOSPI · 2025 revenue ₩1.09T18.8%
75 Global Tax Free KOSDAQ · 2025 revenue ₩154B18.8%
76 GnCenergy KOSDAQ · 2025 revenue ₩263B18.8%
77 INNOX Advanced Materials KOSDAQ · 2025 revenue ₩440B18.6%
78 Anapass KOSDAQ · 2025 revenue ₩108B18.6%
79 Dentium KOSPI · 2025 revenue ₩346B18.5%
80 Silicon 2 KOSDAQ · 2025 revenue ₩1.12T18.4%
81 KoMi KOSDAQ · 2025 revenue ₩604B18.4%
82 SNTEnergy KOSPI · 2025 revenue ₩606B18.4%
83 Naver KOSPI · 2025 revenue ₩12.04T18.3%
84 Hana Materials KOSDAQ · 2025 revenue ₩273B18.3%
85 Sejin Heavy Industries KOSPI · 2025 revenue ₩403B18.2%
86 Osung Advanced Materials KOSDAQ · 2025 revenue ₩166B18.2%
87 Bosung Power Technology KOSDAQ · 2025 revenue ₩147B18.2%
88 Boditech Med KOSDAQ · 2025 revenue ₩162B17.9%
89 Woowon Development KOSDAQ · 2025 revenue ₩376B17.9%
90 Gamsung KOSDAQ · 2025 revenue ₩250B17.8%
91 Hankook Cosmetics Manufacturing KOSPI · 2025 revenue ₩185B17.8%
92 Coway KOSPI · 2025 revenue ₩4.96T17.7%
93 Micro Contact Solution KOSDAQ · 2025 revenue ₩100B17.7%
94 Hansol Chemical KOSPI · 2025 revenue ₩884B17.7%
95 HD Hyundai Marine Solution KOSPI · 2025 revenue ₩1.98T17.7%
96 DUK SAN Neolux KOSDAQ · 2025 revenue ₩344B17.6%
97 WONIK Materials KOSDAQ · 2025 revenue ₩322B17.5%
98 NICE Information Service KOSPI · 2025 revenue ₩602B17.3%
99 JW Holdings KOSPI · 2025 revenue ₩970B17.3%
100 Samyang Comtech KOSDAQ · 2025 revenue ₩155B17.2%

How this is calculated

Consolidated figures where available, standalone otherwise. Holding companies sometimes book dividends from subsidiaries or equity-method income as operating revenue, which can make their margin look very high; companies whose operating profit exceeds revenue are left out.

Normal margins differ widely by industry: software, games and biotech tend to be high, retail and construction low.

Source: financial statement data from periodic reports filed with DART. Figures are as filed; this list is not a recommendation to buy or sell any stock.

Other rankings

Average pay · Tenure · Employees · Director pay · Dividend yield · Dividend growth · Revenue growth · Low debt